By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zogenix, Inc. 

12760 High Bluff Drive
Suite 130
San Diego  California  92130  U.S.A.
Phone: 858-259-1165 Fax: 858-259-1166


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Zogenix (ZGNX) Receives Orphan Drug Designation From FDA For ZX008 In Treatment Of Lennox Gastaut Syndrome 6/22/2017 10:49:15 AM
Zogenix (ZGNX): Could This Be The Greatest Threat To GW Pharma (GWPH)? 6/6/2017 7:02:50 AM
Zogenix (ZGNX) Announces Presentation Of ZX008 Mechanism Of Action Data At Annual Meeting Of Society Of Biological Psychiatry 5/22/2017 8:12:54 AM
Zogenix (ZGNX) Provides Corporate Update And Reports First Quarter 2017 Financial Results 5/5/2017 11:14:43 AM
Zogenix (ZGNX) To Release First Quarter 2017 Financial Results And Host Conference Call And Webcast On May 4 4/27/2017 11:10:23 AM
Zogenix (ZGNX) Completes Enrollment In First ZX008 Phase III Clinical Trial In Dravet Syndrome 4/27/2017 10:29:12 AM
Zogenix (ZGNX) Provides Corporate Update And Reports Fourth Quarter And Full-Year 2016 Financial Results 3/10/2017 11:04:19 AM
Zogenix (ZGNX) To Release Fourth Quarter And Full-Year 2016 Financial Results And Host Conference Call And Webcast On March 9 3/2/2017 8:20:32 AM
Zogenix (ZGNX) Receives Orphan Drug Designation In The European Union For ZX008 In Lennox Gastaut Syndrome 3/1/2017 11:17:32 AM
Zogenix (ZGNX) Announces Initiation Of Clinical Efficacy Portion Of Study 1504 For ZX008 In Dravet Syndrome 2/13/2017 8:17:40 AM
12345678910...
//-->